Cellectar Biosciences (NASDAQ:CLRB)

Cellectar Biosciences (NASDAQ:CLRB)

Share Price
$ 2.23
0.05 (2.29 %)
Market Cap
$20.95 m
Proactive Investors - Run By Investors For Investors

Cellectar Biosciences

Cellectar Biosciences is developing phospholipid drug conjugates (PDCs) designed to provide cancer targeted delivery of diverse oncologic payloads to a broad range of cancers and cancer stem cells. Cellectar’s PDC platform is based on the company’s proprietary phospholipid ether analogs. These novel small-molecules have demonstrated highly selective uptake and retention in a broad range of...

52-week High/Low: $12.76 / $1.22
Market Cap: $20.95 m
col 3
col 4
col 5
col 6

Cellectar Biosciences Timeline

Cellectar Biosciences shares advance by 20% - extending in small measure on the 400% leap seen on Friday after its phospholipid ether analogs as cancer-targeting drug vehicles received their US Patent and Trademarks

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use